BETAAccess all features while we're in beta! Some features may become paid later.Got feedback? Reach us 👉

Loading GNTA charts…

Search ticker or company⌘K

GNTA

01Multicharts 02Comparables 03Price target

May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy

GNTA · Genenta Science S.p.A. fundamentals · vpside

⌘K

GNTAMarket cap $12M/Last filing 20-F · 1 Apr 2026/GNTAMarket cap $12M/Last filing 20-F · 1 Apr 2026/GNTAMarket cap $12M/Last filing 20-F · 1 Apr 2026/GNTAMarket cap $12M/Last filing 20-F · 1 Apr 2026/

Filings synced 13:22 · Prices: prior close 30 Oct

GNTA

Genenta Science S.p.A.

Nasdaq · Biological products, (no diagnostic substances) (SIC 2836)

01Multicharts 02Comparables 03Price target

Add a metric37 metrics

Revenue, quarterly

—

Not reported in this company’s filings

Company filingsvpside.com

Gross margin, trailing twelve months

—

Not reported in this company’s filings

Company filingsvpside.com

Cash and cash equivalents, quarter-end

—

Not reported in this company’s filings

Company filingsvpside.com

Free cash flow, trailing twelve months

—

Not reported in this company’s filings

Company filingsvpside.com

Chart 05 is empty

Chart 06 is empty

Fundamentals: company filings · Q4 = full year − nine months · TTM = last four quarters